Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease
- 1 January 1992
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 123 (1) , 82-89
- https://doi.org/10.1016/0002-8703(92)90750-p
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugsJournal of the American College of Cardiology, 1990
- Sotalol for paroxysmal supraventricular tachycardiasThe American Journal of Cardiology, 1990
- Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmiasThe American Journal of Cardiology, 1990
- Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: Comparison with other antiarrhythmic agentsThe American Journal of Cardiology, 1990
- Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexesThe American Journal of Cardiology, 1990
- Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugsThe American Journal of Cardiology, 1990
- Clinical experience with sotalol in patients with drug-refractory ventricular ArrhythmiasJournal of the American College of Cardiology, 1989
- Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery diseaseThe American Journal of Cardiology, 1988
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970
- Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac TissueCirculation Research, 1970